vimarsana.com

PHARNEXT: Pharnext announces database lock for PXT3003 pivotal Phase III clinical study (PREMIER trial) in Charcot-Marie-Tooth disease type 1A, last step before topline results publication

Card image cap

PHARNEXT: Pharnext announces database lock for PXT3003 pivotal Phase III clinical study (PREMIER trial) in Charcot-Marie-Tooth disease type 1A, last step before topline results publication

finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Related Keywords

Paris , France General , France , United States , Anne Charlotte Dudicourt , Fabreguettes Leib , Gilbert Wagener , Hugo Brugi , Stefan Klotter , Financial Press Relations , Euronext Growth Stock Exchange , Chief Medical Officer , Managing Director , Global Tech Opportunities , Lassen Sie ,

vimarsana.com © 2020. All Rights Reserved.